#3 Go Beyond NCCN

#3 Go Beyond NCCN

The following article is the third in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options Since 2018, the FDA approved 121 new cancer indications, including 49 novel cancer drug entities. The...
#4 Implement Strong Oncology Drug Policies

#4 Implement Strong Oncology Drug Policies

The following article is the second in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options Heath plan drug policies play a critical role in the care delivery process, to ensure that treatment...

Subscribe To Our Newsletter

Join our monthly mailing list to receive the latest news and updates from Oncology Analytics.

You have Successfully Subscribed!